Many children diagnosed with attention deficit hyperactivity disorder are treated with methylphenidate (MPH), despite limited information on later vulnerability to drug abuse. A previous study in adolescent monkeys treated with MPH for 1 year did not indicate differences in acquisition to cocaine reinforcement compared with controls. The present study extended this characterization to include MPH self-administration. Adolescent male rhesus monkeys treated previously with a sustained-release formulation of MPH (beginning at B30 months old) and control monkeys (n = 8/group) were used. All had previous experience of self-administering cocaine under a fixed-ratio 30 schedule of reinforcement. Responding was maintained by food (1.0-g banana-flavored pellets) and MPH (saline, 0.001-0.1 mg/kg/injection) was substituted for food for at least five consecutive sessions. MPH functioned as a reinforcer in all monkeys; there were no differences between groups in MPH self-administration.
Introduction
The number of adolescents who fulfill the DSM criteria for various mental disorders has increased over the past 20 years (cf. Merikangas et al., 2010) . Consistent with these trends, the recent US estimate for the diagnosis of attention deficit hyperactivity disorder (ADHD) in adolescents is B9% (Merikangas et al., 2010) . The diagnosis is frequently accompanied by pharmacotherapies, despite the limited amount of data on the long-term consequences of treating adolescents with psychoactive drugs. Stimulants, such as methylphenidate (MPH), are the first choice of medication for the management of ADHD (Antshel et al., 2011; Swanson et al., 2011) . In fact, MPH is the most widely prescribed stimulant for children, adolescents, and adults with ADHD, owing to its positive effects on academic performance, inattention, impulsivity, and hyperactivity (Solanto, 2002; Crawford et al., 2011; Swanson et al., 2011) . With a 3% annual increase in the percentage of children diagnosed with ADHD from 1997 to 2006 (Pastor and Reuben, 2008) , there has been increasing concern about the effects of MPH on the developing brain and long-term behavioral consequences.
Two recent studies in adolescent rhesus monkeys reported no significant effects on several growth measures following 12-18 months of chronic MPH treatment (Gill et al., 2012; Soto et al., 2012) . In addition, neither study reported any significant effect on several measures of dopamine receptor function as measured with PET.
When cocaine reinforcement was studied, previous MPH treatment did not increase vulnerability (Gill et al., 2012) . In addition to its therapeutic effects, MPH has abuse liability, especially in young adults (Boyd et al., 2006) , and can function as a reinforcer under several conditions in animal models (e.g. Johanson and Schuster, 1975; Bergman et al., 1989; Lile et al., 2003; Alvers et al., 2012; see Kollins et al., 2001 for review). However, the effect of adolescent MPH treatment on subsequent MPH self-administration has not been examined and was the goal of the present study. The hypothesis was that previous exposure to MPH would not differentially affect MPH self-administration when compared with control monkeys.
Materials and methods

Subjects
Sixteen young adult male rhesus monkeys (B6 years old at the start of this study) with a history of MPH (Metadate CD) or vehicle treatment (n = 8/group) and cocaine self-administration (average total cocaine intake 32.4 mg/kg; Gill et al., 2012) were used for the present study. During the previous study, MPH-treated monkeys received, in pudding, clinically relevant doses of 10-15 ng/ml (Swanson and Volkow, 2003) , as determined from monthly blood samples, whereas control monkeys received unadulterated pudding, daily for a total of 12 months, beginning at a mean age of 39 months (Gill et al., 2012) . Monkeys were fed enough Purina monkey chow (#5045; Purina LabDiet, St Louis, Missouri, USA) daily to accommodate growth and maintain food-reinforced responding. Water was freely available in the home cage. All monkeys had previously been surgically implanted with a chronic, indwelling intravenous catheter and associated vascular access port. Animal housing and handling and all experimental procedures were performed in accordance with the 2003 National Research Council Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research and were approved by the Animal Care and Use Committee of Wake Forest University. Environmental enrichment was provided as outlined in the Animal Care and Use Committee of Wake Forest University Non-Human Primate Environmental Enrichment Plan.
Apparatus
Experimental sessions were conducted in ventilated, sound-attenuating chambers (1.5 Â 0.74 Â 0.76 m; Med Associates, St Albans, Vermont, USA). Before placement in the chamber, the monkey's back was cleaned with 95% ethanol and chlorhexidine, and the vascular access port was connected to an infusion pump (Cole-Parmer Instrument Co., Niles, Illinois, USA) located outside the chamber through a 20-G Huber point needle (Access Technologies, Skokie, Illinois, USA) and tubing. The pump was operated for B3 s to fill the port and catheter with the concentration of solution available for that experimental session. On one side of the experimental chamber were two photo-optic switches (Model 117-1007; Stewart Ergonomics Inc., Furlong, Pennsylvania, USA) with a horizontal row of three stimulus lights positioned 14 cm above each switch. A food receptacle was located between the switches and connected to a pellet dispenser (Med Associates) located on the top of the chamber for delivery of 1.0-g banana-flavored food pellets (Bio-Serv, Frenchtown, New Jersey, USA). Monkeys responded on only one of the switches for food or drug and this was counterbalanced between monkeys within each group.
Procedure
All monkeys were trained to respond on either the right or the left photo-optic switch under a fixed-ratio 30 schedule of food reinforcement. Illumination of a green stimulus light served as a discriminative stimulus for food or drug availability. The thirtieth response extinguished the green light and illuminated a white stimulus light above a centrally located food receptacle, followed by the delivery of a food pellet and a 10 s timeout. Sessions ended after 10 or 30 reinforcers (depending on the monkey) or after 60 min had elapsed, whichever occurred first. When saline or MPH (dissolved in sterile 0.9% saline up to a concentration of 100 mg/ml; National Institute on Drug Abuse, Bethesda, Maryland, USA), was substituted for food, sessions ended after 30 injections or 60 min. First, saline was substituted for food until responding decreased by at least 80% of food-maintained response rates for three consecutive sessions. After a return to food-maintained responding, half log-unit doses of MPH (0.001-0.1 mg/kg/injection) were substituted for food for at least five consecutive sessions and until responding was deemed stable. MPH doses were tested in a random order and each dose was separated by at least 2 days of food-maintained responding as described above.
Data analysis
The primary dependent variables were response rates, reinforcement frequency, and total MPH intake per session. For each animal, data were averaged across the last 3 days of availability of each dose. A two-way analysis of variance (treatment group Â MPH dose) was used and post-hoc Bonferroni analyses were also carried out. In all cases, differences were considered statistically significant at the 95% level of confidence (P < 0.05). Data are presented as mean (±SEM) for MPH-treated and control monkeys (n = 8/group).
Results
There were no differences in food-maintained responding between groups, nor were there differences in the number of sessions required for responding to extinguish (< 80% food-maintained response rates when saline was substituted; Table 1 ). For both the MPH-treated and the control monkeys, the response rates varied significantly as a function of MPH dose (F 5,84 = 3.75; P < 0.005) and was characterized as an inverted U-shaped function of dose in both groups (Fig. 1a) . Similarly, reinforcement frequency (Fig. 1b ) varied significantly as a function of MPH dose (F 5,84 = 4.76; P < 0.001). MPH intake increased in a dose-dependent manner and was not different between groups (Fig. 1c) . For all analyses, there was no significant main effect of treatment group and no significant interaction.
Discussion
The present study examined the effects of chronic exposure to MPH, within the range administered to children, in adolescent monkeys, more than 1.5 years after terminating MPH treatment. MPH functioned as a reinforcer in all monkeys, with response rates characterized as an inverted U-shaped function of dose and intake increasing in a monotonic manner. Importantly, there were no differences in the response rates, number of injections, or intake of MPH between the MPH-treated and control monkeys. These results confirm earlier findings in these monkeys (Gill et al., 2012) that MPH treatment in adolescent monkeys does not enhance the reinforcing effects of stimulants.
This is the first animal study to examine the effects of adolescent MPH treatment on later MPH self-administration. It has been hypothesized that MPH has lower abuse liability in humans because of pharmacokinetics (Volkow et al., 1995) , although it is not clear from animal studies that MPH and cocaine have different reinforcing effects. For example, Johanson and Schuster (1975) showed that monkeys with double-lumen catheters would choose equally between MPH and cocaine. Similarly, using rhesus monkeys, Lile et al. (2003) showed that the breakpoints for cocaine and MPH were not significantly different. The present findings are consistent with these findings and extend the research to include the examination of MPH history on subsequent self-administration. In an earlier study using these monkeys, it was reported that MPH treatment did not increase sensitivity to the reinforcing effects of cocaine (Gill et al., 2012) . The present results showing no differences in MPH self-administration in these same monkeys are consistent with mediation of the reinforcing effects of the two stimulant drugs by similar mechanisms.
There are some limitations to the study. It is important to note that previous exposure of these monkeys to cocaine (Gill et al., 2012) 
